male, a 49-year-old man, and a 39-year-old man each developed a white retinal mass associated with laser photocoagulation, lattice degeneration, and treatment of a presumed vascular tumor, respectively. All tumors were white, circumscribed retinal masses that tended to be associated with exudation and either initially or eventually minimal vascularity. Conclusion: Reactive retinal astrocytic tumor can be observed in response to a degenerative, inflammatory, or ischemic retinal insult. Such tumors may progress after therapeutic intervention. 
Introduction
Reactive retinal astrocytic tumors are characterized by a globular yellowish-pink mass, in the inferior retinal periphery, surrounded by lipid exudation with normal-caliber feeder vessels. Other associated features include exudative retinal detachment, retinal and vitreous hemorrhage, and epiretinal membranes, all of which can contribute to loss of vision [1] .
Recently published studies on histopathologic, immunohistochemical, and molecular findings indicate predominance of astrocytes rather than vascular components within the tumor [2, 3] . Hence, reactive retinal astrocytic tumor [2, 3] has been proposed as an alternate terminology to describe these retinal tumors rather than labelling them as a vasoproliferative tumor [4] , presumed acquired hemangioma [5] , and peripheral retinal angioma [6] , angioma-like [7, 8] , angiomatous mass [9] , or peripheral nodular retinal telangiectasis [10] .
We report 3 patients, each with a single retinal tumor with predominant gliotic appearance that could be best labelled as reactive retinal astrocytic tumor. The clinical features of these cases and fine needle aspiration biopsy (FNAB) in 1 case provide further insight into the clinical presentation and progression of reactive retinal astrocytic tumors.
Case Reports
Case 1 A 6-year-old female with a diagnosis of bilateral idiopathic retinal vasculitis that had been treated ( Fig. 1 a) with panretinal photocoagulation and systemic steroids and methotrexate. Initial fluorescein angiography shows anomalous retinal vessels and extensive areas of nonperfusion ( Fig. 1 b) . She presented with a rapidly growing multilobulated white retinal tumor (11.0 × 7.5 × 2.8 mm) in her right eye and neovascular glaucoma in the left eye. The tumor was associated with lipid exudation and centered over the area of previous laser photocoagulation scar ( Fig. 1 c) . FNAB revealed benign cells with abundant fibrillar cytoplasm consistent with glial cells ( Fig. 1 d) . Treatment with multiple sessions of double freeze-thaw cryotherapy and intravitreal bevacizumab was undertaken. One year following completion of local therapy and discontinuation of systemic therapy (steroids and methotrexate), the visual acuity was 20/60 with regression of the tumor and resolution of lipid exudation.
Case 2
A 49-year-old man was referred because of a retinal mass that was detected on a routine eye examination. Past medical history was pertinent for controlled insulin-dependent diabetes. Examination revealed best corrected visual acuity of 20/20 OU (-2.00 + 0.50 × 170; -3.00 + 0.50 × 40). Anterior segment examination of both eyes and fundus examination of the right eye was unremarkable. In the left eye, a white retinal mass (8.0 × 5.0 × 2.0 mm) in vicinity of the lattice degeneration without associated exudation was observed ( Fig. 2 a) . Fluorescein angiography revealed absence of prominent feeder or intrinsic vessels ( Fig. 2 b) . On ultrasonography B and A scan, the lesion was irregularly structured with high internal reflectivity. The lesion has remained stable under observation over 1.5 years.
Case 3
A 39-year-old man presented with a retinal hemorrhagic vascular mass involving the inferior periphery of the right eye (8.0 × 6.0 × 2.4 mm). The mass was associated with surrounding lipid exudation. A clinical diagnosis of vasoproliferative tumor of the retina was made ( Fig. 3 a) . He was treated with episcleral brachytherapy without complications (iodine-125 plaque, 12 mm size, 45 Gy delivered over 48 h). Because of lack of response and onset of proliferative retinopathy, intravitreal bevacizumab was administered (1.25 mg in 0.05 mL). Within 4 weeks, the tumor appeared totally avascular and gliotic ( Fig. 3 b) .
Discussion
As the terminology suggests, retinal astrocytic tumors are believed to be reactive rather than low-grade proliferations as the cells within the tumors have bland nuclei, do not exhibit mitoses, and have low Ki-67 proliferative indices [2] . The tumors also lack BRAF-KIAA gene rearrangement and IDH1-R132H mutation, which are markers of an astrocytoma [2, 11] . In the central nervous system, the process of reactive astrocytosis is believed to represent a form of homeostatic mechanism to insults such as trauma, ischemia, inflammation, and others [12] that helps isolate the affected region from the neighbouring tissues, thereby limiting the lesion size [13] .
These tumors are also known to occur secondary to a variety of retinal insults such as inflammation (pars planitis), degenerative disorder (retintis pigmentosa), and trauma (retinal detachment surgery) [4, 14] . Case 1 with a diagnosis of bilateral idiopathic retinal vasculitis had been treated with panretinal photocoagulation. She presented with a rapidly growing multilobulated white retinal tumor (11.0 × 7.5 × 2.8 mm) associated with lipid exudation that centered over the area of previous laser photocoagulation scar. FNAB revealed only glial cells. The vascularity within the tumor was not evident on fundoscopy and on fluorescein angiography. Moreover, there was only localized pinpoint hemorrhage after diagnostic FNAB that revealed only astrocytes. Case 2 of an incidentally detected white retinal mass (8.0 × 5.0 × 2.0 mm) in the vicinity of lattice degeneration was without obvious retinal vascularity. In Case 3, a hemorrhagic ret-inal vascular mass transformed into a white retinal mass after treatment with episcleral brachytherapy and intravitreal bevacizumab, interventions that target retinal vasculature inducing regression of existing or new vessels [15, 16] . The findings in our patients are consistent with the reactive nature of this tumor, which may occur in a variety of settings. These tumors are slow growing, variably vascularized, and may eventually be classified as massive gliosis of the retina [17] .
Related rare entities such as presumed solitary circumscribed retinal astrocytic proliferation [18] [19] [20] have clinical appearance of a white circumscribed, retinal lesion without prominent retinal vascularity in absence of associated subretinal fluid or hemorrhage and may be included within the spectrum of reactive retinal astrocytic tumors as well as acquired astrocytomas (not associated with tuberous sclerosis) that are composed of astrocytes lacking mitotic figures [21, 22] . 
